Usefulness of Contrast Enhanced Harmonic Endoscopic Ultrasound for

Status Completed

Clinical Trial Summary

The study evaluates the role of contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) for the differentiation of the pancreatic cysts and their malignant potential.

Clinical Trial Description

Due to the increase use of cross-sectional imaging techniques for varied medical conditions more and more pancreatic cysts are incidentally found. Magnetic resonance imaging revealed a prevalence of incidental pancreatic cystic neoplasm (PCN) in adults between 2,4-49,1% and autopsy studies showed that half of the individuals had pancreatic cysts. There is a great variety of pancreatic cysts, they are mainly divided in neoplastic or non-neoplastic (i.e pseudocyst). Pseudocysts appear after acute or chronic pancreatitis and represent only 20% of all pancreatic cysts.. PCN include a diverse group of pancreatic cysts including mucin-producing (Intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN)) and nonmucin-producing lesions (Serous cystadenoma (SCN), Solid pseudopapillary neoplasm(SPN) cystic neuroendocrine tumor(cNET)) with different morphology and progression to malignancy. SPN's,cNET are considered premalignant or malignant conditions and require surveillance or surgical resection. SCN instead are benign and surveillance is not necessary. Resection is considered only if symptoms are present. The discrimination between the different cyst types is crucial for the therapeutic approach. Their morphology can be similar and sometimes it's a challenge to diagnose them.There are many tools but none is good enough to be used alone. Contrast-enhanced harmonic endoscopic ultrasound using low mechanical index (0.12-0.4) is an additional test to assess the vascularization of the cystic wall and the septa and solid component for the differential diagnosis of PCN. Our aim was to identify specific imaging characteristics using CH-EUS in order to increase the diagnostic accuracy for potential malignant pancreatic cysts. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04389892
Study type	Interventional
Source	Iuliu Hatieganu University of Medicine and Pharmacy
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2018
Completion date	May 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05572788` - Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts	N/A
Completed	`NCT01770405` - Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract	N/A
Completed	`NCT01643460` - Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts	N/A
Recruiting	`NCT03260842` - Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Recruiting	`NCT04291651` - UCSF PANC Cyst Registry
Recruiting	`NCT05692596` - The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Recruiting	`NCT03334708` - A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Recruiting	`NCT04140435` - EUS-guided Through-the-needle Microforceps Biopsy Outcomes
Terminated	`NCT00550108` - Management of Incidentally Discovered Pancreatic Cysts	Phase 3
Recruiting	`NCT03492151` - Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Completed	`NCT03169842` - Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts	N/A
Not yet recruiting	`NCT06320990` - Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection	Phase 1
Recruiting	`NCT04404101` - Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies	N/A
Recruiting	`NCT06305728` - A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting	`NCT06340620` - EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope	N/A
Recruiting	`NCT02343692` - A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas	N/A
Recruiting	`NCT02775461` - Pancreas Registry and High Risk Registry
Active, not recruiting	`NCT01563133` - Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas	N/A
Completed	`NCT00222898` - Cancer Detection in Pancreatic Cysts	N/A
Not yet recruiting	`NCT06276764` - The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Usefulness of Contrast Enhanced Harmonic Endoscopic Ultrasound for Pancreatic Cysts

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms